Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2508 of 6351
-
Could assigning one main nurse to each patient cut hospital infections and falls?
Disease control CompletedThe aim of this quasi-experimental before-after study is to evaluate whether the implementation of the Primary Nursing (PN) pattern of care improves nursing-sensitive outcomes in adult inpatients and nurse-related outcomes across hospital wards in Northern Italy. The main questi…
Sponsor: Università degli Studi del Piemonte Orientale Amedeo Avogadro • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Blood test may spot returning colorectal cancer earlier
Knowledge-focused Recruiting nowThis study investigates if circulating tumor DNA (ctDNA) and other tumor-related molecules/chemicals released in the blood can help doctors predict if colorectal cancer may come back or spread. Tumors shed DNA and other cancer related chemicals into the blood that can be identifi…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Triple-Drug cocktail targets Hard-to-Treat cancers
Disease control OngoingThis phase Ib trial seeks to identify the side effects and best dose of the combination of copanlisib and olaparib when given together with durvalumab. The trial will evaluate how well the drug combinations work in treating patients with advanced cancers who have solid tumors tha…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New genetic panel could personalize cancer treatment
Knowledge-focused OngoingNational multicenter prospective study, involving the enrollment of approximately 1,500 patients with ovarian cancer, 1,500 patients with breast cancer, and 1,000 patients with colorectal cancer.
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New schizophrenia drug passes long-term safety check
Disease control CompletedA clinical study to evaluate the long-term safety and tolerability of an investigational drug in people with schizophrenia. This study is accepting male and female participants between 18 years old -65 years old who have been diagnosed with schizophrenia. This study will be cond…
Phase 3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Supplement shows promise for kidney Patients' heart health
Disease control OngoingRisk of cardiovascular diseases (CVD) is significantly elevated in patients with chronic kidney disease (CKD); however, this increased risk is only partially explained by traditional CV risk factors. Arterial dysfunction is an important nontraditional CV risk factor gaining incre…
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Robot arm aims for perfect knee ligament repair
Disease control Recruiting nowAccurate ideal graft tunnel positioning is essential for the successful application of anatomic anterior cruciate ligament (ACL) reconstruction. The accurate insertion of the tibial tunnel (TT) and femoral tunnel (FT) remain a challenge. A robotic assisted new strategy for drill…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Sickle cell drug voxelotor tested for Long-Term safety – but trial ends early
Disease control Stopped earlyOpen-label extension study of voxelotor for participants with Sickle Cell Disease who have participated in voxelotor clinical trials.
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Simple test for throat cancer on the horizon?
Knowledge-focused Recruiting nowThe purpose of this research is to identify a biomarker that is exists when human papillomavirus (HPV) mediated oropharyngeal squamous cell carcinoma is present and does not exist when HPV mediated oropharyngeal squamous cell carcinoma is absent.
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Cancer patients may not need lifelong immunotherapy, study suggests
Knowledge-focused CompletedBased on the overwhelming positive response to this survey and the large number of patients being treated with PD-1/PD-L1 therapy in the UPMC system, the investigators are proposing a trial that will randomize patients who have disease stability to stop treatment at 1 year or con…
Phase 3 • Sponsor: Dan Zandberg • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New drug cocktail aims to shrink mesothelioma before surgery
Disease control OngoingThis study will test whether giving nivolumab in combination with pemetrexed and either cisplatin or carboplatin before surgery is a safe and effective approach to treating resectable mesothelioma without delaying surgery.
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 16:52 UTC
-
Once-Daily pill may protect blood vessels better in black kidney transplant patients
Disease control OngoingThe primary purpose of this study is to evaluate the pulse wave velocity and vascular compliance measurements at the beginning and the end of the study while the participants are taking either extended release tacrolimus tablets (known by brand name Envarsus XR®, and also referre…
Phase 4 • Sponsor: Roy D. Bloom, MD • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Gentle brain zaps may help stroke survivors regain spatial awareness
Disease control CompletedIntroduction Stroke is the main cause of disability in the world and its sequelae have a great impact in the functional independence and quality of life of patients and families. Unilateral spatial neglect is one of the most frequent cognitive deficits after stroke, and its main…
Sponsor: Universitat Oberta de Catalunya • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Texting parents may help keep babies at a healthy weight
Prevention CompletedA randomized controlled trial enrolling 900 parent-infant dyads (English and Spanish speaking) comparing Greenlight (control), a behavioral intervention focusing on nutrition, physical activity, media use, and sleep as compared to Greenlight Plus (intervention) which includes the…
Sponsor: Vanderbilt University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 07:54 UTC
-
Cancer drug shows promise for Alzheimer's in tiny study
Disease control CompletedThis is an open-label, pilot study designed to explore whether daratumumab may have a clinically meaningful effect in patients with mild to moderate Alzheimer's disease.
Phase 2 • Sponsor: Marc L Gordon, MD • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Scientists hunt for new treatments for liver metastases in colorectal and pancreatic cancers
Knowledge-focused Recruiting nowLiver metastases (MTS) are the main cause of death for patients affected by colorectal carcinoma (CRC) and pancreatic ductal adenocarcinoma (PDAC), thus representing the major unmet clinical need for these malignancies. Based on preliminary and published data, the investigators …
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Could a russian drug boost brain function in chronic ischemia?
Disease control CompletedThe purpose of this study is to evaluate safety and efficacy of sequential treatment with Mexidol® in patients with chronic cerebral ischemia (CCI).
Phase 3 • Sponsor: Pharmasoft • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
MRI-Guided radiation aims to safely boost liver tumor treatment
Disease control Recruiting nowThe purpose of this trial is to identify a safe maximum tolerated dose level for MRI-guided Stereotactic Body Radiation Therapy (SBRT) treatment of bowel and liver metastases, respectively. Eligible participants will be on study for up to 12 months.
Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New coaching model boosts cardiac rehab use in seniors
Disease control CompletedModified Application of Cardiac Rehabilitation for Older Adults (MACRO) responds to a critical underuse of cardiac rehabilitation in older adults with a coaching model that addresses issues related to aging as a means to better facilitate cardiac rehabilitation (CR). MACRO is a r…
Sponsor: Daniel Forman, MD • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Can a Pocket-Sized defibrillator deliver when it counts?
Knowledge-focused Recruiting nowThis post market clinical follow-up study is a multi-center, non-randomized, unblinded, observational registry of the performance of the FRx Automated external defibrillator (AED) used in conjunction with electrodes with or without use of the infant/child key. The registry is foc…
Sponsor: Heartstream US LLC • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC